The Barry L. MacLean Professor of Molecular Engineering Innovation and Enterprise
Institute for Molecular Engineering
Jeffrey Hubbell designs materials to assemble in such a way that they can stimulate the immune system to fight infection or malignancy, or turn off some aspects in order to address auto-immune diseases such as type-1 diabetes. He has coined the term “immuno-modulatory materials” to describe this newly emerging field of research. Along with his associates, he holds 77 patents. An entrepreneurial materials scientist, Hubbell has founded three companies based on his academic research.
A recipient of the National Science Foundation’s Presidential Young Investigator Award, he is a member of the National Academy of Engineering and an elected fellow of the American Association for the Advancement of Science.
Hubbell received his PhD in chemical engineering from Rice University. He was previously a member of the chemical engineering faculty at the University of Texas and the California Institute of Technology. He also served as a professor of biomedical engineering and director of the Institute for Biomedical Engineering at the Swiss Federal Institute of Technology and the University of Zurich. He moved to the École Polytechnique Fédérale de Lausanne (EPFL) in 2003, to serve as founding director of the Institute of Bioengineering.
Hubbell joined the University of Chicago faculty in 2014.